Citius Oncology (CTOR)
NASDAQ:CTOR
US Market
Holding CTOR?
Track your performance easily

Citius Oncology (CTOR) Financial Statements

44 Followers

Citius Oncology Financial Overview

Citius Oncology's market cap is currently ―. The company's EPS TTM is $0.244; its P/E ratio is 5.35; Citius Oncology is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 24Sep 23Dec 22Sep 22Jun 22
Income Statement-
Total Revenue--$ 0.00--
Gross Profit-----
EBIT$ 252.46K-$ -138.12K--
EBITDA$ 252.46K-$ -138.12K--
Net Income Common Stockholders$ 252.46K-$ 380.81K--
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 261.00$ 0.00$ 289.18K$ 0.00$ 0.00
Total Assets$ 49.19M$ 47.73M$ 68.19M$ 42.69M$ 210.58K
Total Debt$ 1.72M$ 0.00$ 0.00$ 0.00$ 0.00
Net Debt$ 1.72M$ 0.00$ -289.18K$ 0.00$ 0.00
Total Liabilities$ 52.23M$ 22.20M$ 31.84K$ 6.42M$ 220.69K
Stockholders Equity$ -3.04M$ 25.54M$ 68.16M$ 36.27M$ -10.11K
Cash Flow-
Free Cash Flow--$ -47.97K--
Operating Cash Flow--$ -47.97K--
Investing Cash Flow-----
Financing Cash Flow-----
Currency in USD

Citius Oncology Earnings and Revenue History

Citius Oncology Debt to Assets

Citius Oncology Cash Flow

Citius Oncology Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis